QuasipanaxatriolCAS# 171903-78-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 171903-78-9 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C30H50O3 | M.Wt | 458.7 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Quasipanaxatriol can greatly enhance the cytotoxicity of the anti-cancer drugs in P388/ADM cells. |
Quasipanaxatriol Dilution Calculator
Quasipanaxatriol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1801 mL | 10.9004 mL | 21.8007 mL | 43.6015 mL | 54.5019 mL |
5 mM | 0.436 mL | 2.1801 mL | 4.3601 mL | 8.7203 mL | 10.9004 mL |
10 mM | 0.218 mL | 1.09 mL | 2.1801 mL | 4.3601 mL | 5.4502 mL |
50 mM | 0.0436 mL | 0.218 mL | 0.436 mL | 0.872 mL | 1.09 mL |
100 mM | 0.0218 mL | 0.109 mL | 0.218 mL | 0.436 mL | 0.545 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- n-Tridecane
Catalog No.:BCN9855
CAS No.:629-50-5
- 3-Hydroxybenzoic acid
Catalog No.:BCN9854
CAS No.:99-06-9
- 2-Benzal-4-hydroxyacetophenone
Catalog No.:BCN9853
CAS No.:2657-25-2
- Colchiceine
Catalog No.:BCN9852
CAS No.:477-27-0
- Helveticoside
Catalog No.:BCN9851
CAS No.:630-64-8
- Flavonol
Catalog No.:BCN9850
CAS No.:577-85-5
- alpha-Ionone
Catalog No.:BCN9849
CAS No.:127-41-3
- Gardenin A
Catalog No.:BCN9848
CAS No.:21187-73-5
- Urushiol (15:3)
Catalog No.:BCN9847
CAS No.:83543-37-7
- Vitexin 7-glucoside
Catalog No.:BCN9846
CAS No.:35109-95-6
- 9-Hydroxy-O-senecioyl-8,9-dihydrooroselol
Catalog No.:BCN9845
CAS No.:31456-63-0
- Tryptanthrine
Catalog No.:BCN9844
CAS No.:13220-57-0
- 5,6-Benzoflavone
Catalog No.:BCN9857
CAS No.:6051-87-2
- alpha-Peltatin
Catalog No.:BCN9858
CAS No.:568-53-6
- Vanillic acid glucoside
Catalog No.:BCN9859
CAS No.:32142-31-7
- Sphenanlignan
Catalog No.:BCN9860
CAS No.:866347-36-6
- Solanidine
Catalog No.:BCN9861
CAS No.:80-78-4
- Somnifericin
Catalog No.:BCN9862
CAS No.:173693-57-7
- 3,29-O-Dibenzoyloxykarounidiol
Catalog No.:BCN9863
CAS No.:389122-01-4
- ICG-001
Catalog No.:BCN9864
CAS No.:780757-88-2
- 4-(4-Methoxyphenyl)-2-butanone
Catalog No.:BCN9865
CAS No.:104-20-1
- Tropic acid
Catalog No.:BCN9866
CAS No.:529-64-6
- 1,2-Dimethoxybenzene
Catalog No.:BCN9867
CAS No.:91-16-7
- 15-Methoxy-16-oxo-15,16H-strictic acid
Catalog No.:BCN9868
CAS No.:1356388-38-9
Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.[Pubmed:7480200]
Planta Med. 1995 Oct;61(5):409-13.
Examined in vitro were the effects of some triterpenoids from Panax (Araliaceae) and Glycyrrhiza (Leguminosae) spp. on the sensitivity to daunomycin (DAU) and vinblastine (VBL) of adriamycin (ADM)-resistant P388 leukemia cells (P388/ADM), which were resistant to multiple anticancer drugs. Quasipanaxatriol, 20(S)-protopanaxatriol, ginsenoside Rh2, and compound K greatly enhanced the cytotoxicity of the anti-cancer drugs in P388/ADM cells. The extent of enhancement was different among the triterpene compounds; the 4- to 46-fold increase in DAU cytotoxicity was observed in P388/ADM cells in the presence of non-toxic or marginally toxic concentrations of individual compounds, while those for VBL were in the ratios of 2- to 37-fold. The maximum increase in cytotoxicity was observed with 50 microM Quasipanaxatriol; the resistance indices defined to be the ratios of the IC50 values for P388/ADM and P388 parental cells decreased from 79 to 1.7 and from 180 to 4.9 in the cases of DAU and VBL, respectively. The reversal of DAU resistance in P388/ADM by Quasipanaxatriol could be explained by the effective accumulation of the drugs mediated by the DAU-efflux blockage.